312 related articles for article (PubMed ID: 21748243)
21. Decreased serum paraoxonase 1 (PON1) activity: an additional risk factor for atherosclerotic heart disease in patients with PCOS?
Dursun P; Demirtaş E; Bayrak A; Yarali H
Hum Reprod; 2006 Jan; 21(1):104-8. PubMed ID: 16155079
[TBL] [Abstract][Full Text] [Related]
22. Paraoxonase, oxidized low density lipoprotein, monocyte chemoattractant protein-1 and adhesion molecules are associated with macrovascular complications in patients with type 2 diabetes mellitus.
Sozer V; Himmetoglu S; Korkmaz GG; Kaya S; Aydin S; Yumuk V; Hatemi H; Uzun H
Minerva Med; 2014 Jun; 105(3):237-44. PubMed ID: 24988089
[TBL] [Abstract][Full Text] [Related]
23. Effect of PON1 polymorphism on HDL antioxidant potential is blunted with aging.
Cherki M; Berrougui H; Isabelle M; Cloutier M; Koumbadinga GA; Khalil A
Exp Gerontol; 2007 Aug; 42(8):815-24. PubMed ID: 17532162
[TBL] [Abstract][Full Text] [Related]
24. Human paraoxonase-1 overexpression inhibits atherosclerosis in a mouse model of metabolic syndrome.
Mackness B; Quarck R; Verreth W; Mackness M; Holvoet P
Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1545-50. PubMed ID: 16627808
[TBL] [Abstract][Full Text] [Related]
25. Higher Levels of Oxidized Low Density Lipoproteins in Alzheimer's Disease Patients: Roles for Platelet Activating Factor Acetyl Hydrolase and Paraoxonase-1.
Bacchetti T; Vignini A; Giulietti A; Nanetti L; Provinciali L; Luzzi S; Mazzanti L; Ferretti G
J Alzheimers Dis; 2015; 46(1):179-86. PubMed ID: 25720407
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of oxidative stress markers in first trimester for assessment of preeclampsia risk.
Genc H; Uzun H; Benian A; Simsek G; Gelisgen R; Madazli R; Güralp O
Arch Gynecol Obstet; 2011 Dec; 284(6):1367-73. PubMed ID: 21344259
[TBL] [Abstract][Full Text] [Related]
27. Serum paraoxonase 1 activity and lipid peroxidation levels in patients with age-related macular degeneration.
Baskol G; Karakucuk S; Oner AO; Baskol M; Kocer D; Mirza E; Saraymen R; Ustdal M
Ophthalmologica; 2006; 220(1):12-6. PubMed ID: 16374043
[TBL] [Abstract][Full Text] [Related]
28. PON1 activity is inversely related to LDL apoB carbonyl content in patients with coronary artery disease.
Sharma R; Singh B; Mahajan M
Kaohsiung J Med Sci; 2007 May; 23(5):225-31. PubMed ID: 17525004
[TBL] [Abstract][Full Text] [Related]
29. PON1 status is influenced by oxidative stress and inflammation in coronary heart disease patients.
Kotur-Stevuljevic J; Spasic S; Jelic-Ivanovic Z; Spasojevic-Kalimanovska V; Stefanovic A; Vujovic A; Memon L; Kalimanovska-Ostric D
Clin Biochem; 2008 Sep; 41(13):1067-73. PubMed ID: 18634772
[TBL] [Abstract][Full Text] [Related]
30. Serum paraoxonase activity is decreased in the active stage of Behçet's disease.
Karakucuk S; Baskol G; Oner AO; Baskol M; Mirza E; Ustdal M
Br J Ophthalmol; 2004 Oct; 88(10):1256-8. PubMed ID: 15377545
[TBL] [Abstract][Full Text] [Related]
31. Levels of asymmetric dimethylarginine, nitric oxide and lipid peroxidation markers in patients with end-stage renal disease having peritoneal dialysis treatment.
Göçmen AY; Sahin E; Koçak H; Tuncer M; Gümüşlü S
Clin Biochem; 2008 Jul; 41(10-11):836-40. PubMed ID: 18457672
[TBL] [Abstract][Full Text] [Related]
32. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants.
Aviram M; Rosenblat M; Billecke S; Erogul J; Sorenson R; Bisgaier CL; Newton RS; La Du B
Free Radic Biol Med; 1999 Apr; 26(7-8):892-904. PubMed ID: 10232833
[TBL] [Abstract][Full Text] [Related]
33. Levels of paraoxonase and arylesterase activities and malondialdehyde in workers exposed to ionizing radiation.
Serhatlioglu S; Gursu MF; Gulcu F; Canatan H; Godekmerdan A
Cell Biochem Funct; 2003 Dec; 21(4):371-5. PubMed ID: 14624476
[TBL] [Abstract][Full Text] [Related]
34. Relationship among plasma secretory phospholipase A2, oxidized low density lipoprotein & paraoxonase activities in hypertensive subjects treated with angiotensin converting enzyme inhibitors.
Konukoglu D; Firtina S; Serin O; Cavusoglu C
Indian J Med Res; 2009 Apr; 129(4):390-4. PubMed ID: 19535833
[TBL] [Abstract][Full Text] [Related]
35. [Study of the association between paraoxonase1 55 Met/Leu, paraoxonase2 148 Ala/Gly and manganese superoxide dismutase (MnSOD) 9 Ala/Val genetic polymorphisms and coronary heart disease].
Chi DS; Ling WH; Ma J; Xia M; Hou MJ; Wang Q; Zhu HL; Tang ZH; Yu XP
Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Sep; 27(9):808-13. PubMed ID: 17299970
[TBL] [Abstract][Full Text] [Related]
36. Levels of paraoxonase, an index of antioxidant defense, in patients with active sarcoidosis.
Uzun H; Yanardag H; Gelisgen R; Genc H; Uygun S; Vehid S; Karter Y; Demirci S
Curr Med Res Opin; 2008 Jun; 24(6):1651-7. PubMed ID: 18474147
[TBL] [Abstract][Full Text] [Related]
37. Renal cortical thickness and PON1 activity both decrease in chronic renal failure.
Ak G; Ozgönül M; Sözmen EY; Aslan SL; Sözmen B
J Nephrol; 2002; 15(2):144-9. PubMed ID: 12018630
[TBL] [Abstract][Full Text] [Related]
38. Synergistic effects of BuChE non-UU phenotype and paraoxonase (PON1) 55 M allele on the risk of systemic lupus erythematosus: influence on lipid and lipoprotein metabolism and oxidative stress, preliminary report.
Bahrehmand F; Vaisi-Raygani A; Rahimi Z; Ahmadi R; Kiani A; Tavilani H; Vaisi-Raygani H; Pourmotabbed T
Lupus; 2014 Mar; 23(3):263-72. PubMed ID: 24399815
[TBL] [Abstract][Full Text] [Related]
39. Association between oxidant/antioxidant markers and proteinuria in type 2 diabetes: results in 142 patients.
Rashidi A; Nakhjavani M; Esteghamati A; Asgarani F; Khalilzadeh O; Abbasi M; Safari R
J Nephrol; 2009; 22(6):733-8. PubMed ID: 19967652
[TBL] [Abstract][Full Text] [Related]
40. Medroxyprogesterone acetate, enoxaparin and pentoxyfylline cause alterations in lipid peroxidation, paraoxonase (PON1) activities and homocysteine levels in the acute oxidative stress in an experimental model of spinal cord injury.
Topsakal C; Kilic N; Erol FS; Kaplan M; Akdemir I; Tiftikci M; Gursu F
Acta Neurochir (Wien); 2002 Oct; 144(10):1021-31; discussion 1031. PubMed ID: 12382130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
